NCT06051565 - Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 6, 2021

Primary Completion Date

June 13, 2022

Study Completion Date

September 15, 2022

Conditions

DiabetesMagnetic Resonance Imaging

Interventions

DRUG

Polysaccharide superparamagnetic iron oxide injection

Polysaccharide superparamagnetic iron oxide injection can be used for the treatment of iron-deficiency anemia and for magnetic resonance imaging enhancement.

Trial Locations (1)

101149

Beijing Luhe Hospital, Capital Medical University, Beijing